Markets
ACA insurance
(Sherwood News)

Selling government-sponsored insurance is looking less lucrative. It’s about to get even messier.

Cuts to Medicaid and signs that ACA enrollees are becoming costlier are weighing on some insurers. Is Centene the canary in the coal mine?

Providing healthcare on behalf of the government might be becoming less lucrative than it used to be.

On Tuesday, Centene, the largest seller of Affordable Care Act plans, tanked after it withdrew its 2025 guidance because new data showed its ACA enrollees are using their benefits significantly more than expected, which threatens to eat into profits. The government pays insurers to cover ACA enrollees based on how sick they are assumed to be.

Centene is down by about 40% Wednesday, setting it up for its worst single day since it went public in 2001.

The ACA, which passed in 2010 and took effect in 2014, gave millions of Americans access to healthcare by expanding who is eligible for Medicaid. It also created a multibillion-dollar revenue stream for insurance companies. Some struggled to offer profitable plans, in some cases even dropping off the ACA Marketplace, but the market eventually leveled and insurers like Centene wound up making up a majority of their business via the government.

The news from Centene also dragged down other insurers, including Oscar Health and Molina Healthcare. Oscar, a digital-first newcomer, does make some money from ACA plans, but not nearly as much as others. It’s also a retail favorite vulnerable to speculation.

Molina, on the other hand, is in a similar boat as Centene. Nearly all of its revenue comes from selling Medicare and Medicaid plans. The company fell 20% on Wednesday.

But sicker ACA enrollees may be just the start of their problems.

President Trump and his supporters in Congress have made it their mission to cut government spending on social programs, and Medicaid and Medicare are at the top of their list. Republicans are pushing a bill that would result in the largest cut to Medicaid in history, threatening to shrink a key revenue stream.

UnitedHealthcare, the insurance arm of the conglomerate United Health Group, is also down for the year, but not quite for the same reasons.

UNH, the largest health insurer in the country, gets a larger sum of its revenue from Medicare Advantage. The program allows American seniors to get their government-funded healthcare through a private insurer. UNH said in its most recent earnings report that its Medicare Advantage costs were higher than expected.

Higher costs are also not the company’s only issue. The head of its insurance arm, Brian Thompson, was killed in Manhattan in December in a high-profile shooting, with alleged gunman Luigi Mangione having expressed frustration with healthcare companies. UnitedHealth ousted its CEO in May amid increased government scrutiny over potential fraud in its Medicare Advantage program as well as antitrust probe. A whistleblower report by The Guardian set it back another notch.

UNH and its peers may not have an easy time winning over lawmakers and regulators, even if cutting their revenue streams means Americans, especially the poor and vulnerable, will die.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

markets

Nike sinks to lowest level since 2014 after warning of “challenged” sales environment in Q4 report

Did Nike do it?

Investors had a mixed reaction after the global sports apparel company reported its fourth quarter earnings on Tuesday after the bell. Shares initially rose 5% as Nike beat out Wall Street expectations amid a hefty tariff refund bonus. However, the stock then sank to its lowest level since August 2014 in postmarket trading.

Here are the Q4 numbers:

  • Revenue of $11.0 billion (estimate: $10.8 billion).

  • Adjusted earnings per share of $0.20 (estimate: $0.12).

Ahead of this report, Nike warned that results would be flattered by a one-time tariff refund (now estimated at roughly $0.52 per share for the bottom line). That gave the company an extra cushion in snapping its streak of seven quarters of year-over-year profit declines.

Over the past year, the company had been punished by tariffs on imported goods, stagnant consumer spending, and increasing competition from other footwear brands like New Balance, Adidas, and Hoka.

Outgoing CFO Matthew Friend deemed it an “increasingly challenging operating environment, where sell-through remains challenged.”

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.